Edwards Lifesciences Corp (EW) Stock Price, Quote & News

Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. I...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 250 2500

Website: www.edwards.com

Address:

One Edwards Way, Irvine, United States

BillionerOfKing Jan. 13 at 6:16 PM

$EW Current Stock Price: $83.00 Contracts to trade: $80 EW Jan 16 2026 Call Entry: $3.10 Exit: $5.11 ROI: 65% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

AStrokeOfLuck Jan. 10 at 8:35 PM

$EW

0 · Reply

catacal_ Jan. 9 at 10:31 AM

$EW CATALYST: J.P. Morgan Healthcare Conference is happening on Mon. Jan. 12 at 2:15 PM. Don't get blindsided by upcoming catalysts. Track this catalyst and more at: https://www.catacal.com/catalyst/jp-morgan-healthcare-conference-5 $SPY $QQQ

0 · Reply

OMW2Money Jan. 7 at 8:29 PM

$IHI been waiting on this sector for awhile now, is it time for it to finally make a move? $ABT $ISRG $BSX $EW

1 · Reply

SantosSquire1021 Jan. 6 at 5:17 PM

$ARGX $EA $D $EW $VLO Great flow

0 · Reply

ZacksResearch Dec. 26 at 6:10 PM

🚨 $EW just scored a first-of-its-kind FDA approval — this is a big deal. Edwards Lifesciences won FDA approval for SAPIEN M3, the first transseptal TMVR therapy, expanding minimally invasive options for high-risk mitral regurgitation patients. That “first” status matters. ⚡ See why this approval could be a game-changer 👉 https://www.zacks.com/stock/news/2809373/ew-wins-fda-approval-for-sapien-m3-as-first-transseptal-tmvr-therapy?cid=sm-stocktwits-2-2809373-teaser-26486&ADID=SYND_STOCKTWITS_TWEET_2_2809373_TEASER_26486

0 · Reply

ZacksResearch Dec. 26 at 5:10 PM

$EW's SAPIEN M3 gets FDA nod — game changer for mitral valve treatment? 🚀 Edwards Lifesciences secures FDA approval for the SAPIEN M3, the first minimally invasive, catheter-based system for mitral regurgitation, expanding their transcatheter portfolio and potentially boosting long-term growth. Discover why $EW's stock is one to watch 👉 https://www.zacks.com/stock/news/2809373/ew-wins-fda-approval-for-sapien-m3-as-first-transseptal-tmvr-therapy?cid=sm-stocktwits-2-2809373-body-26487&ADID=SYND_STOCKTWITS_TWEET_2_2809373_BODY_26487

0 · Reply

AnachronismA Dec. 25 at 4:48 AM

$EW The next inflection point emerges from the pace at which operating leverage materializes relative to expectations, with outcomes shaped by timing and discipline. Missteps risk prolonged valuation stagnation.

0 · Reply

AStrokeOfLuck Dec. 23 at 5:36 PM

$EW

0 · Reply

Thelonius_Stonk Dec. 23 at 5:06 PM

$EW 👀

0 · Reply

Edwards Lifesciences Corporation (EW) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 9, 2026, 6:48 PM EST - 4 days ago

Edwards Comments on JenaValve Acquisition

Jan 9, 2026, 4:17 PM EST - 4 days ago

FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve

Dec 24, 2025, 12:45 PM EST - 20 days ago

HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 23, 2025, 9:00 AM EST - 21 days ago

FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy

Dec 18, 2025, 7:05 AM EST - 26 days ago

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 11, 2025, 8:52 AM EST - 4 weeks ago

Edwards Lifesciences Corporation (EW) Analyst/Investor Day Transcript

Dec 4, 2025, 9:00 AM EST - 5 weeks ago

Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference

Nov 25, 2025, 1:24 PM EST - 7 weeks ago

Top small-cap plays for 2026

A COHR DG TXT VLO

Nov 20, 2025, 8:40 AM EST - 7 weeks ago

Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And Exits

BA BFAM CWAN EPS LSCC MOD MPWR

Nov 9, 2025, 4:00 PM EST - 2 months ago

Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease

Oct 30, 2025, 9:26 PM EDT - 2 months ago

Edwards Lifesciences Corporation (EW) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 5:02 PM EDT - 2 months ago

Edwards Lifesciences beats quarterly estimates on strength in heart devices

Oct 30, 2025, 4:38 PM EDT - 2 months ago

Edwards Lifesciences CFO Scott Ullem to step down by mid-2026

Oct 30, 2025, 4:15 PM EDT - 2 months ago

Edwards Lifesciences Announces CFO Transition Plan

Oct 30, 2025, 4:13 PM EDT - 2 months ago

Edwards Lifesciences Reports Third Quarter Results

Oct 28, 2025, 9:37 AM EDT - 2 months ago

Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights

Oct 27, 2025, 8:44 PM EDT - 2 months ago

EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

Oct 27, 2025, 3:06 PM EDT - 2 months ago

Successful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025

Oct 27, 2025, 2:22 PM EDT - 2 months ago

Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025

Oct 23, 2025, 7:05 AM EDT - 2 months ago

Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025

Oct 22, 2025, 6:31 PM EDT - 2 months ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW

Oct 16, 2025, 6:00 PM EDT - 3 months ago

EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

Oct 14, 2025, 2:36 PM EDT - 3 months ago

Edwards Lifesciences: Inflection Incoming, But When?

Aug 29, 2025, 9:09 AM EDT - 4 months ago

Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care

Aug 19, 2025, 4:15 PM EDT - 5 months ago

Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase

Aug 14, 2025, 4:16 PM EDT - 5 months ago

Edwards Lifesciences Corporation Investors: Company Investigated by the Portnoy Law Firm

Aug 7, 2025, 9:45 PM EDT - 5 months ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX BSX EXAS GH ISRG LLY MASI

Aug 6, 2025, 2:17 PM EDT - 5 months ago

JenaValve Responds to FTC's Action Against Proposed Edwards Lifesciences Acquisition

Aug 6, 2025, 1:41 PM EDT - 5 months ago

FTC seeks to block Edwards Lifesciences' acquisition of JenaValve

Aug 6, 2025, 1:40 PM EDT - 5 months ago

Edwards Lifesciences Comments on FTC's Action to Block Proposed Acquisition of JenaValve

Aug 6, 2025, 12:20 PM EDT - 5 months ago

Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027

Jul 31, 2025, 9:52 AM EDT - 5 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM ISRG LLY PODD SYK

Jul 25, 2025, 1:49 PM EDT - 6 months ago

Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance

Jul 25, 2025, 9:53 AM EDT - 6 months ago

Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results

Jul 24, 2025, 11:07 PM EDT - 6 months ago

Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 4:53 PM EDT - 6 months ago

Edwards Lifesciences raises annual sales forecast on strong demand for heart devices

Jul 24, 2025, 4:15 PM EDT - 6 months ago

Edwards Lifesciences Reports Second Quarter Results

Jul 23, 2025, 9:57 AM EDT - 6 months ago

Five years after COVID, pharma shares languish in US policy limbo

ABBV ABT ALNY AZN LLY MRK NVO

Jul 18, 2025, 7:05 AM EDT - 6 months ago

Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025

Jun 4, 2025, 2:11 PM EDT - 7 months ago

Edwards Lifesciences: With A Heart Beating Strong And Steady

May 22, 2025, 2:30 AM EDT - 8 months ago

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

May 19, 2025, 2:13 PM EDT - 8 months ago

Trade Tracker: Bill Baruch buys Edwards Lifesciences

May 6, 2025, 7:05 AM EDT - 9 months ago

Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

May 1, 2025, 8:00 AM EDT - 9 months ago

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

Apr 24, 2025, 2:42 PM EDT - 9 months ago

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

Apr 23, 2025, 9:35 PM EDT - 9 months ago

Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript

Apr 23, 2025, 5:43 PM EDT - 9 months ago

Edwards Lifesciences raises 2025 sales forecast after robust quarter

Apr 23, 2025, 4:15 PM EDT - 9 months ago

Edwards Lifesciences Reports First Quarter Results

BillionerOfKing Jan. 13 at 6:16 PM

0 · Reply

AStrokeOfLuck Jan. 10 at 8:35 PM

$EW

0 · Reply

catacal_ Jan. 9 at 10:31 AM

0 · Reply

OMW2Money Jan. 7 at 8:29 PM

$IHI been waiting on this sector for awhile now, is it time for it to finally make a move? $ABT $ISRG $BSX $EW

1 · Reply

SantosSquire1021 Jan. 6 at 5:17 PM

$ARGX $EA $D $EW $VLO Great flow

0 · Reply

ZacksResearch Dec. 26 at 6:10 PM

0 · Reply

ZacksResearch Dec. 26 at 5:10 PM

0 · Reply

AnachronismA Dec. 25 at 4:48 AM

0 · Reply

AStrokeOfLuck Dec. 23 at 5:36 PM

$EW

0 · Reply

Thelonius_Stonk Dec. 23 at 5:06 PM

$EW 👀

0 · Reply

GettnFibbywIT Dec. 23 at 3:39 PM

$EW $XLV $IHI Just sayin' - Price still trying to get above........

0 · Reply

ZacksResearch Dec. 22 at 5:45 PM

Winning streaks into 2026? Big MedTech says yes. 🏥📈 Four large-cap MedTech leaders — $MDT, $ISRG, $CAH, and $EW — appear well-positioned to keep momentum going into 2026, backed by resilient procedure demand and ongoing innovation driving their businesses. Want the full breakdown on what’s powering these names? See the full MedTech outlook here 👉 https://www.zacks.com/stock/news/2807489/4-large-cap-medtech-stocks-to-keep-winning-streaks-alive-in-2026?cid=sm-stocktwits-2-2807489-teaser-25846&ADID=SYND_STOCKTWITS_TWEET_2_2807489_TEASER_25846

0 · Reply

JarvisFlow Dec. 18 at 1:40 PM

JP Morgan updates rating for Edwards Lifesciences ( $EW ) to Overweight, target set at 90 → 100.

0 · Reply

JarvisFlow Dec. 17 at 7:59 PM

Canaccord Genuity has adjusted their stance on Edwards Lifesciences ( $EW ), setting the rating to Hold with a target price of 89 → 87.

0 · Reply

JackDarwin Dec. 17 at 1:14 PM

$EW Bullish Engulfing Candlestick Pattern formed. Wait for the confirmation from the next day's candle.

0 · Reply

JarvisFlow Dec. 16 at 11:31 AM

Baird has updated their rating for Edwards Lifesciences ( $EW ) to Neutral with a price target of 87.

0 · Reply

JarvisFlow Dec. 11 at 8:59 PM

Citigroup updates rating for Edwards Lifesciences ( $EW ) to Buy, target set at 96 → 101.

0 · Reply

ZacksResearch Dec. 11 at 1:29 PM

$EW's TAVR business is on fire! 🚀 With a 10.6% YoY growth in Q3 2025, FDA approval for asymptomatic AS patients, and broad-based adoption of the SAPIEN platform in Europe, Edwards is positioned for a strong run. Find out what could drive Edwards higher 👉 https://www.zacks.com/stock/news/2802754/should-you-continue-to-hold-ew-stock-in-your-portfolio?cid=sm-stocktwits-2-2802754-body-24362&ADID=SYND_STOCKTWITS_TWEET_2_2802754_BODY_24362

0 · Reply

ZacksResearch Dec. 11 at 12:10 PM

Is $EW still worth a spot in your portfolio? 🤔 The headline is raising the exact question long-term holders should be asking — whether EW remains a hold or if the risk/reward has shifted. That alone tells me this is a moment to reassess the setup. Dig into the full hold-or-fold breakdown here 👉 https://www.zacks.com/stock/news/2802754/should-you-continue-to-hold-ew-stock-in-your-portfolio?cid=sm-stocktwits-2-2802754-teaser-24336&ADID=SYND_STOCKTWITS_TWEET_2_2802754_TEASER_24336

0 · Reply

GettnFibbywIT Dec. 8 at 3:52 PM

$EW $XLV $IHI Would you look at that...A big area for EW bulls to overcome/close above:

0 · Reply

JarvisFlow Dec. 8 at 3:38 PM

Barclays updates rating for Edwards Lifesciences ( $EW ) to Overweight, target set at 99 → 103.

0 · Reply

JarvisFlow Dec. 5 at 7:13 PM

Canaccord Genuity has updated their rating for Edwards Lifesciences ( $EW ) to Hold with a price target of 89.

0 · Reply

Market Cap	48.17B
Revenue (ttm)	5.44B
Net Income (ttm)	4.17B
EPS (ttm)	N/A
PE Ratio	33.12
Forward PE	29.72
Profit Margin	76.75%
Debt to Equity Ratio	0.06

Volume	4,061,200
Avg Vol	3,528,696
Day's Range	N/A - N/A
Shares Out	580.30M
Stochastic %K	31%
Beta	0.95
Analysts	Strong Sell
Price Target	$96.32